BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 3, 2000
View Archived Issues
Creative BioMolecules' OP-1 Implant enters regulatory review process during Q3 1999
Read More
Cell Genesys receives payment from Japan Tobacco
Read More
Phase II study of Fabry's disease treatment successfully completed
Read More
Medarex and IDM establish broad collaborative agreement
Read More
Interneuron signs major partnerships and focuses resources during 1999
Read More
Company Profile: Onyvax
Read More
Levotech completes phase IIb study of seven-day contraceptive patch
Read More
Cell Based Delivery receives NIST grant for cardiovascular program
Read More
Immunomedics/IBC develop new fusion protein for use in cancer therapy
Read More
Incara completes sale of antibacterial division
Read More
Nonpeptide endothelin antagonists from Warner-Lambert selective for ETA receptors
Read More
Abbott investigates new compounds for angiogenesis-related disorders
Read More
Preparation and use of MMP inhibitors described by Bayer
Read More
Merck describes thrombin-specific anticoagulants
Read More
Centaur's new NRTs and their use for treating, preventing IBD
Read More
Phenylalanine derivatives selective for alpha4 integrins discovered by Celltech
Read More
Specific VLA-4 inhibitor designed at Biogen for cell adhesion-mediated pathologies
Read More
Metabotropic glutamate receptor agonist tested in anxiety and addiction models
Read More
SmithKline Beecham patents novel ERK/MAP kinase inhibitors
Read More
NDA filed for intranasal scopolamine during fourth quarter
Read More
Antiangiogenic activity of troponin I may involve direct inhibition of bFGF and VEGF receptors
Read More
CFC-free flunisolide to be developed by 3M/Forest partnership
Read More
ViroPharma licenses Battelle's drug delivery technology for its anti-RSV products
Read More
Preclinical pharmacokinetics of SB-240563 support clinical development for asthma
Read More
Potent new nonpeptide bradykinin B2 receptor antagonist selected by Fournier for further development
Read More